Dividend-News

Daily dividend news for investors in dividend stocks


Risk-Tolerant Healthcare Investors Should Look To Pharmaceutical Stocks For Dividend Income

Published Thu, 14 Sep 2017 08:05:54 -0400 on Seeking Alpha

Investors should consider healthcare stock classifications as a very diverse equity market. A mutual fund classified as “healthcare,” for example, can cover a wide range of businesses such as provider groups, pharmaceutical companies, health insurance companies, healthcare technology, and biotechnology. With the plethora of investment choices, income-oriented investors have numerous options when it comes to buying healthcare stocks that pay dividends. However, healthcare investors seeking a reliable and mostly predictable cash distribution should focus on the pharmaceutical sector.

In an environment where income-oriented investors have few investment options without acquiring risk, healthcare provides an opportunity for equities with reliable, years-long track records of generating income through dividends. Of all the sub-sectors in healthcare, better opportunities for dividends, especially for short-term investors, lie with pharmaceutical companies. Unlike the healthcare systems, pharmaceutical manufacturers are for-profit corporations. Pharmaceutical companies derive their profit from the creation of innovative drugs and drug therapies. Assuming the drug is granted a 20-year patent, the Food and Drug Administration (FDA) tests the drugs over a period of years. The pharmaceutical company can then utilize the remaining time on the patent to earn profits as the exclusive provider of that drug. Once the patent expires, competitors can sell generic versions of... Read more

Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
GLAXOSMITHKLINE 41.24   22.3 1.85 2.36 5.83
MEDICAL PROPERTIES TRUST 18.84   6.8 2.76 1.00 5.49
ASTRAZENECA 42.59   25.0 1.70 1.86 4.32
PFIZER 42.35   22.8 1.86 1.44 3.40
KINDRED HEALTHCARE 9.20   0.0 -6.02 0.12 1.30

GLAXOSMITHKLINE - GSK
GLAXOSMITHKLINE - GSK  


Older articles featuring Glaxosmithkline (GSK):
Parking Cash In The Large Cap 5% Dividend Club
Lanny's January Dividend Income Summary
5%+ Dividend Yield Portfolio: Profiting Handsomely From Volatility (Jan 2019 Review)
High Yield Stocks For Investors Looking For Income Options
5%+ Dividend Yield Portfolio: Beating The Market 2 Of The Last 3 Years (December 2018 Review)
5%+ Dividend Yield Portfolio: Profiting From A Return To Normal (October 2018 Review)
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November
Bert's October Dividend Income Summary
5%+ Dividend Yield Portfolio: Playing Offense, Not Running Scared (October 2018 Review)
5%+ Dividend Yield Portfolio: Ignore The Political Circus (Sep 2018 Review)

More